Sinonasal cancer patients wanted for Long-Term observation study
NCT ID NCT04755855
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 200 sinonasal cancer patients over time to understand how the disease progresses, how treatments affect survival, and how patients feel. Researchers will also analyze tumor genetics to learn more about the cancer's molecular makeup. No new treatments are being tested—this is purely an observation and data-gathering effort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SINONASAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug tazemetostat offered to patients with rare, aggressive tumors
- Rare sinus cancer study aims to clarify treatment outcomes
- Radiation-Free hope: study tests if surgery alone is enough for rare nasal cancer
- New drug duo aims to make inoperable sinus cancer removable
- New drug combo shows promise for Tough-to-Treat head and neck cancer
- New chemo approach may spare sinus cancer patients from major surgery